Live Breaking News & Updates on Marzone Chems

Stay updated with breaking news from Marzone chems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Late But Not Too Late | Submitting Post-Filing Data During Patent Prosecution in Selected Jurisdictions | Kilpatrick Townsend & Stockton LLP


To embed, copy and paste the code into your website or blog:
Intellectual Property counsel often face the dilemma of when to file a patent application: as soon as possible, or wait and gather more support? Filing an application “early” helps to avoid anticipatory prior art but if the application is filed too early, the applicant may risk rejections during examination for lack of supportive evidence.
On the other hand, if the application is filed too late, the applicant may lose the priority date. This is especially problematic for biopharma industry applicants where on one hand, these data are often critical for securing a patent; on the other hand, the research and development cycle is long and generating experimental and clinical trial data require significant resources and time to obtain, and business and financial reasons can also render it difficult to predict when the data will become available. Frequently supporting data and related information are not available ....

United States , United Kingdom , South Korea , Republic Of Korea , Marzone Chems , Chiteki Zaisan , Hoechst Marion Roussel , Eli Lilly , Energy Rentals Inc , European Patent Office , Yeda Research Development Co , Intas Pharmaceutical Ltd , Honble Delhi High Court , Supreme People Court , Trademark Office , Indian Patent Office , Japan Patent Office Examination Guidelines , Ajanta Pharma Ltd , Korean Intellectual Property Office , Eli Lilly Canada Inc , See Eli Lilly Co , Amgen Court , Kilpatrick Townsend Stockton , High Court , Allergan Inc , Patent Office ,